1.Develop and manage relationship with KOLs and conduct KOL activities:
? Provide KOLs professional support on product information and disease state, including scientific data (including health economics data etc.) , meeting abstracts and professional literature
? Proactive discussions on-label and reactive discussions for unsolicited questions with compliance
2.Track and analyze targeting KOLs advocacy, contribution and publication status, working closely with business partners to establish 1st-tier and 2nd-tier KOL pool in the individual region, draft KOL management strategy and engagement plan
3. Inter**** with medical societies and advisory boards:
Answer medical / scientific queries of medical societies with regards to DSPC products organize / support / participate in advisory boards and round-table discussions to build KOL advocacy (including agenda development, scientific materials preparation, presentation communication)
4. As medical speaker to present at company/society sponsored activities for up-to-date scientific and clinical information on DSPC product
5. Participation in congresses and conventions:
Use congresses and conventions to network with KOLs, establish new contacts, gather competitive intelligence, up-date stakeholders accordingly and booth support
6. Clinical trials and PMS support, including company sponsored, IIT program etc., collect HCP’s insights on IIT and feed back to medical affairs advisor facilitate submission of IIT proposal, communicate and track the study progress and completion
7. Sales force training:
? Organize face to face meeting or Webex meeting to update medical information to improve sale team’s medical ability
? Present at POA and regional sales meetings for medical information
? Provide assistance to MA on training to commercial colleagues on disease states, medicines or other areas of interest as required
8. Participate in brand team activities to provide medical input

是一家總部位于日本東京的研發(fā)型制藥企業(yè)，在全球范圍內(nèi)研發(fā)、生產(chǎn)、銷售創(chuàng)新型醫(yī)藥產(chǎn)品。致力于通過提供創(chuàng)新而可靠的醫(yī)藥產(chǎn)品，為全世界人民的健康做出貢獻。憑借先進的科學技術和研發(fā)能力，不斷挑戰(zhàn)目前尚未滿足人們需求的醫(yī)療領域，立志在目標治療領域中成為全球專業(yè)市場領導者。
集團已經(jīng)在需要高度專業(yè)技能的器官移植領域和泌尿領域成為全球專業(yè)治療領域領導者。借助獨特的產(chǎn)品線，逐步在其他目標領域培養(yǎng)支柱產(chǎn)品。在抗腫瘤領域，擁有了先進的抗體藥物研究技術。